Chesapeake Utilities Corporation operates as an energy delivery company in the United States. It operates through two segments: Regulated Energy and Unregulated Energy. The Regulated Energy segment ...

FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...

Tom Orsborn: Victor Wembanyama on the elevated level of play that he obviously had a big part in making happen: “I think it was pretty good. We got a guy like Kawhi going for 30, making every shot. No ...

The latest news on airports globally, with updates on financing, infrastructure expansion and sustainability initiatives.

After high-profile water crises like the one in Flint, Michigan, some Americans distrust the safety of tap water, choosing to purchase drinking water from freestanding water vending machines or kiosks ...

The Korea Fair Trade Commission (KFTC) has initiated sanctions procedures against starch sugar manufacturing and sales companies over alleged collusion, following similar cases involving sugar and ...

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical ...

Key insight: Spending among consumers is still robust, despite some weakening economic indicators, New York Fed researchers said Tuesday. Supporting data: Total credit-card balances rose 5.7% in 2025, ...

The latest news on airports globally, with updates on financing, infrastructure expansion and sustainability initiatives.

Drivers with accidents, speeding tickets or DUI convictions pay some of the highest rates for car insurance of any demographic. A single at-fault collision, for example, can spike your premiums 45% or ...

Good morning, and welcome to the conference call for Tate & Lyle's Q3 Trading Statement. Your speakers today are Nick Hampton, Chief Executive; and Sarah Kuijlaars, Chief Financial Officer. I will now ...

Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD), announced at the MDA (Muscular Dystrophy ...